Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-12 Purchase | 2023-09-14 4:38 pm | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 20,000 | $5.19 | $103,800 | 9,530,340 (Indirect Direct) | View |
| 2023-08-08 Purchase | 2023-08-09 12:22 pm | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 30,000 | $5.9 | $177,000 | 1,421,642 (Indirect) | View |
| 2023-05-26 Purchase | 2023-05-26 2:53 pm | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 14,500 | $6.85 | $99,325 | 283,959 (Indirect Direct) | View |
| 2023-05-26 Purchase | 2023-05-26 2:50 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 153,000 | $6.5211 | $997,728 | 56,012,493 (Direct) | View |
| 2022-12-16 Purchase | 2022-12-20 10:18 am | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 85,102 | $10.1 | $859,249 | 55,859,493 (Direct) | View |
| 2022-08-19 Purchase | 2022-08-22 3:27 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 200,000 | $11.46 | $2,292,460 | 55,844,391 (Direct) | View |
| 2022-06-13 Purchase | 2022-06-15 1:14 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 64,088 | $8.0344 | $514,908 | 55,644,391 (Direct) | View |
| 2022-06-06 Purchase | 2022-06-08 3:32 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 64,545 | $7.4981 | $483,965 | 55,580,303 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-17 3:07 pm | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 200,000 | $6.3389 | $1,267,780 | 9,260,340 (Indirect Direct) | View |
| 2022-05-13 Purchase | 2022-05-17 3:04 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 300,000 | $7.2551 | $2,176,530 | 55,515,758 (Direct) | View |
| 2022-05-12 Purchase | 2022-05-16 2:14 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 1,408,468 | $6.4054 | $9,021,801 | 55,215,758 (Direct) | View |
| 2022-05-12 Purchase | 2022-05-16 2:13 pm | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 85,000 | $5.79 | $492,150 | 269,459 (Indirect Direct) | View |
| 2022-03-04 Purchase | 2022-03-04 4:51 pm | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 10,000 | $8.54 | $85,400 | 61,000 (Indirect Direct) | View |
| 2022-03-01 Purchase | 2022-03-03 12:06 pm | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 20,000 | $9.05 | $181,000 | 51,000 (Indirect Direct) | View |
| 2022-02-28 Purchase | 2022-03-01 7:49 pm | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 230,789 | $8.66 | $1,998,633 | 9,060,340 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-24 Exercise | 2023-08-25 1:57 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 63,075,184 (Direct) | View |
| 2023-08-24 Exercise | 2023-08-25 1:57 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 63,075,184 (Direct) | View |
| 2023-05-26 Exercise | 2023-05-30 1:14 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 63,075,184 (Direct) | View |
| 2023-05-26 Exercise | 2023-05-30 1:14 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 63,075,184 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 3:02 pm | N/A 2027-03-23 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 250,000 | $0 | 12,653,029 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 3:02 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 250,000 | $0.19 | 12,653,029 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-23 4:33 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 62,922,184 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-23 4:33 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 62,922,184 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 2:31 pm | N/A 2026-06-15 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0 | 6,089,940 (Direct) | View |
| 2022-12-20 Gift | 2022-12-22 2:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0 | 6,089,940 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 2:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0.19 | 6,089,940 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:34 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Lo Andrew Director | 47,231 | $0 | 138,556 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:33 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 47,231 | $0 | 497,045 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:30 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 47,231 | $0 | 627,045 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:28 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 462,535 | $0 | 3,392,689 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:22 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer | 346,901 | $0 | 2,658,381 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:19 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 485,661 | $0 | 5,870,481 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:13 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 925,069 | $0 | 6,613,691 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-21 9:36 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 61,912,013 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-21 9:36 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 61,912,013 (Direct) | View |
| 2022-10-31 Gift | 2022-11-09 7:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 70,000 | $0 | 55,774,391 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-22 3:09 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 61,782,013 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-22 3:09 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 61,782,013 (Direct) | View |
| 2022-05-18 Exercise | 2022-05-19 1:17 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 61,653,380 (Direct) | View |
| 2022-05-18 Exercise | 2022-05-19 1:17 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 61,653,380 (Direct) | View |
| 2022-02-22 Exercise | 2022-02-25 1:50 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 59,944,912 (Direct) | View |
| 2022-02-22 Exercise | 2022-02-25 1:50 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 59,944,912 (Direct) | View |
Ownership | 2022-02-03 7:00 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 0 | $0 | 8,829,551 (Indirect) | View |
| 2021-11-30 Ownership | 2022-02-03 7:00 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 333,333 | $0 | 8,829,551 (Direct) | View |
| 2021-05-24 Ownership | 2022-02-03 6:58 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 2,000,000 | $0 | 53,807,290 (Direct) | View |
Ownership | 2022-02-03 6:56 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 0 | $0 | 54,031,790 (Direct) | View |
| 2021-05-24 Ownership | 2022-02-03 6:56 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 2,223,500 | $0 | 54,031,790 (Indirect) | View |
Ownership | 2022-02-03 6:54 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 0 | $0 | 184,459 (Indirect) | View |
| 2021-12-10 Ownership | 2022-02-03 6:54 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 500,000 | $0 | 184,459 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 5:00 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 500,000 | $0.32 | 6,069,279 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 5:00 pm | 2020-03-23 2029-08-22 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 500,000 | $0 | 6,069,279 (Direct) | View |
| 2021-12-03 Option Award(A) | 2021-12-10 2:36 pm | N/A 2031-12-03 | AbCellera Biologics Inc. | ABCL | Lo Andrew Director | 91,325 | $0 | 91,325 (Direct) | View |
| 2021-08-27 Option Award | 2021-12-10 1:15 pm | 2022-08-27 2031-08-27 | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 79,814 | $0 | 1,145,096 (Direct) | View |
| 2021-08-27 Option Award | 2021-12-10 1:13 pm | 2022-08-27 2031-08-27 | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 79,814 | $0 | 2,515,738 (Direct) | View |